As of 2026-04-20, the Relative Valuation of Akoya Biosciences Inc (AKYA) is (23.12) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.29 USD, the upside of Akoya Biosciences Inc based on Relative Valuation is -1892.6%.
The range of the Relative Valuation is (22.12) - (23.35) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.2x - 27.7x | 25.4x |
| Forward P/E multiples | 21.0x - 24.5x | 23.2x |
| Fair Price | (22.12) - (23.35) | (23.12) |
| Upside | -1814.4% - -1910.3% | -1892.6% |
| Date | P/E |